Adenomyosis

Changed by Ammar Haouimi, 22 May 2018

Updates to Article Attributes

Body was changed:

Adenomyosis of the uterus is a common, benign uterine pathology. It is thought by many to be on the spectrum of endometriosis, with ectopic endometrial tissue in the myometrium. Adenomyosis may present with menorrhagia and dysmenorrhoea. Ultrasound and MRI are imaging modalities that may show characteristic findings.

Epidemiology

Adenomyosis typically affects women of reproductive age. In general, affected women are multiparous, and the condition is seen with higher frequency in a woman with a history of uterine surgical procedures (e.g. Caesarian section, dilatation and curettage). It has a reported incidence that ranges widely from 5 to 70%, depending on the histological definition or the imaging modality used 12.

Clinical presentation

Most patients with adenomyosis are asymptomatic. Symptoms related to adenomyosis include dysmenorrhoea, menorrhagia, dyspareunia, chronic pelvic pain, and menometrorrhagia 11. The ectopic endometrial glands within the myometrium do not respond to cyclic ovarian hormones, unlike those of endometriosis.

Pathology

Adenomyosis is histologically-defined by the presence of ectopic endometrial tissue within the myometrium. Benign invasion of the myometrium by the endometrium also results in adjacent smooth muscle hyperplasia. It has been postulated that this dysfunctional hypertrophied muscular tissue surrounding the ectopic endometrial glands prevents uterine contractions from tamponading bleeding myometrial arterioles; hence, these patients frequently present with dysfunctional uterine bleeding or menorrhagia.

Associations

Radiographic features

Imaging features are variable and in many instances very subtle. Three (some say four) forms can be distinguished:

Adenomyosis is usually relatively generalised, affecting large portions of the uterus (typically the posterior wall), but sparing the cervix. Despite often marked enlargement of the uterus, the overall contour is usually preserved 5.

In some cases, adenomyosis may be localised, forming a mass. In such cases, the term adenomyoma may be used, although there appears to be some disagreement about whether the terms focal adenomyosis and adenomyoma refer to exactly the same entity (please refer to the article on adenomyoma for further discussion).

A rare variant is cystic adenomyosis which is believed to be the result of repeated focal haemorrhages resulting in cystic spaces filled with altered blood products 5.

Ultrasound

Pelvic ultrasound is usually the first and often the only imaging modality employed to investigate menorrhagia and dysmenorrhoea. Unfortunately, the sonographic features of adenomyosis are variable and may be absent. The reported sensitivity and specificity of transabdominal ultrasound are 32-63% and 95-97% respectively 7.

The spectrum of findings includes:

  • normal-appearing uterus
  • focal or diffuse myometrial bulkiness, typically of the posterior wall 5
  • thickening of the transition zone can sometimes be visualised as a hypoechoic halo surrounding the endometrial layer of ≥12 mm thickness
  • subendometrial echogenic linear striations
  • subendometrial echogenic nodules (specific sign)
  • small myometrial cysts / subendometrial cysts (specific sign)
  • heterogeneous echogenicity (heterogeneous myometrial echotexture) 1-2
    • hyperechoic: islands of endometrial glands
    • hypoechoic: associated muscle hypertrophy
    • a "Venetian blind" appearance may be seen due to subendometrial echogenic linear striations and acoustic shadowing where endometrial tissues cause a hyperplastic reaction

When an adenomyoma is present, appearances may closely mimic those of a uterine fibroid, which may also co-exist.

Hysterosalpingogram (HSG)

May show diverticula extending into the myometrium 3.

CT

CT is unable to diagnose adenomyosis but may suggest its presence when uterine enlargement is present. Distinguishing between adenomyosis and uterine fibroids on CT is difficult, if not impossible, although the presence of calcifications strongly favours the latter 5.

MRI

Pelvic MRI is the modality of choice to diagnose and characterise adenomyosis, and T2-weighted images (sagittal and axial) are most useful. MRI has a sensitivity of 78-88% and a specificity of 67-93% 7.

The most easily recognised feature is thickening of the junctional zone of the uterus to more than 12 mm, either diffusely or focally (normal junctional zone thickness is up to ~5 mm) 5.

  • T2
    • typically a region of adenomyosis appears as an ill-defined ovoid/diffuse region of thickening, often with small high T2 signal regions representing small areas of cystic change
    • the region may also have a striated appearance 5
  • T1
    • foci of high T1 signal are often seen, indicating menstrual haemorrhage into the ectopic endometrial tissues 7
  • T1 C+ (Gd)
    • contrast-enhanced MRI evaluation is usually not indicated for evaluation of adenomyosis, however, if performed, it shows enhancement of the ectopic endometrial glands

Treatment and prognosis

Treatment depends on the severity of symptoms and the need to preserve fertility. In some instances, suppression of normal cyclical hormone-induced proliferation of endometrial tissue (e.g. GnRH agonist) is sufficient.

In women with severe symptoms not relieved medically, and in whom fertility is no longer desirable, a hysterectomy may be performed.

History and etymology

It was first described by Rokitansky in 1860 as “cystosarcoma adenoides uterinum” and was later defined by Von Recklinghausen in 1896 11

Differential diagnosis

The differential depends on the macroscopic distribution of endometrial tissue.

For diffuse disease consider:

For focal disease (adenomyoma) consider:

Whether focal or diffuse, another potential differential is treatment of breast cancer with tamoxifen which can lead to poorly-defined endometrial hyperplasia and endometrial polyps that can mimic adenomyosis 4 (see: tamoxifen-associated endometrial changes).

  • +<li><a href="/articles/myometrial-metastases">myometrial metastases </a></li>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.